A. Vorsters

P. van Damme, X. Bosch, A. Vorsters, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Hepatitis B control in Europe by universal vaccination programmes: The situation in 2001

P. van Damme, A. Vorsters, 2002, Journal of medical virology.

Comparison between Urine and Cervical Samples for HPV DNA Detection and Typing in Young Women in Colombia

P. van Damme, P. González, R. Herrero, 2016, Cancer Prevention Research.

Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine

A. Floore, C. Meijer, P. van Damme, 2021, Molecules.

Should female sex workers be offered HPV vaccination?

P. van Damme, A. Hogewoning, M. F. Schim van der Loeff, 2019, Human vaccines & immunotherapeutics.

Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda

S. Franceschi, P. van Damme, M. Tommasino, 2016, International journal of cancer.

Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox

H. Goossens, N. Hens, P. van Damme, 2017, Scientific Reports.

Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011.

P. van Damme, D. Fitzsimons, G. Hendrickx, 2013, Vaccine.

Which interventions improve HPV vaccination uptake and intention in children, adolescents and young adults? An umbrella review

E. Karafillakis, G. Prue, S. M. Sherman, 2022, Sexually Transmitted Infections.

Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR

S. Franceschi, P. Snijders, M. Tommasino, 2016, Journal of Clinical Microbiology.

The role of healthcare providers in HPV vaccination programs - A meeting report.

N. Muñoz, P. van Damme, E. Franco, 2019, Papillomavirus research.

Human papillomavirus detection in urine: Effect of a first-void urine collection device and timing of collection.

P. van Damme, K. Beyers, V. Vankerckhoven, 2019, Journal of virological methods.

Urine testing for HPV: rationale for using first void

P. van Damme, G. Clifford, A. Vorsters, 2014, BMJ : British Medical Journal.

Optimization of HPV DNA detection in urine by improving collection, storage, and extraction

M. Ieven, P. Damme, A. Vorsters, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells

H. Goossens, P. van Damme, E. Smits, 2014, Journal of cellular and molecular medicine.

Hepatitis B Vaccines

P. van Damme, G. Hendrickx, Jade Pattyn, 2021, The Journal of infectious diseases.

Clinical Performance of the RealTime High Risk HPV Assay on Self-Collected Vaginal Samples within the VALHUDES Framework

S. Weyers, M. Arbyn, G. Donders, 2022, Microbiology spectrum.

Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study.

S. Weyers, M. Arbyn, W. Tjalma, 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The use of urine in the follow-up of HPV vaccine trials

P. van Damme, S. Van Keer, A. Vorsters, 2015, Human vaccines & immunotherapeutics.

Detection of human papillomavirus DNA in urine. A review of the literature

M. Ieven, P. Damme, J. Bilcke, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples

P. van Damme, X. Van Ostade, M. Ieven, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

A cohesive European policy for hepatitis B vaccination, are we there yet?

P. van Damme, L. Mosina, T. Lernout, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Hepatitis A and E: update on prevention and epidemiology.

P. van Damme, D. Fitzsimons, G. Hendrickx, 2010, Vaccine.

Incentives and barriers regarding immunization against influenza and hepatitis of health care workers.

P. van Damme, D. Fitzsimons, T. Lernout, 2014, Vaccine.

Prevention of viral hepatitis (B and C) reassessed.

K. Herck, K. Van Herck, P. Damme, 2008, Best practice & research. Clinical gastroenterology.

Burden and prevention of viral hepatitis in the Arctic region, Copenhagen, Denmark, 22–23 March 2012

B. McMahon, P. van Damme, D. Fitzsimons, 2013, International journal of circumpolar health.

Identification and management of persons with chronic viral hepatitis in Europe

D. Fitzsimons, P. Damme, G. Hendrickx, 2012 .

Prevention and control of viral hepatitis through adolescent health programmes in Europe.

P. van Damme, K. Hoppenbrouwers, D. Fitzsimons, 2007, Vaccine.

The clock is running, ...

K. Van Herck, A. Vorsters, P. Van Damme, 2009, Vaccine.

Advances in hepatitis immunization (A, B, E): public health policy and novel vaccine delivery

P. van Damme, G. Hendrickx, A. Vorsters, 2012, Current opinion in infectious diseases.

Urine biomarkers in cancer detection: A systematic review of preanalytical parameters and applied methods

P. Pauwels, K. Beyers, V. Vankerckhoven, 2023, International journal of cancer.

Human papillomavirus vaccination in adults: impact, opportunities and challenges – a meeting report

M. Poljak, S. Kjaer, M. Stanley, 2021, BMC Proceedings.

Overcoming barriers in HPV vaccination and screening programs.

S. de Sanjosé, P. van Damme, P. Lopalco, 2017, Papillomavirus research.

Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report

N. Muñoz, F. Bosch, C. Simas, 2020, BMC Proceedings.

Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening.

M. Poljak, K. Cuschieri, M. Baay, 2021, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

HPV immunization programs: Ensuring their sustainability and resilience.

P. van Damme, A. Vorsters, 2018, Vaccine.

Human Papillomavirus (HPV) Vaccines and Their Impact

P. van Damme, Jade Pattyn, A. Vorsters, 2021, Encyclopedia of Virology.

Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature

P. van Damme, V. Matheeussen, W. Tjalma, 2019, Papillomavirus research.

Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.

J. Doyen, S. Weyers, M. Arbyn, 2021, Gynecologic oncology.

Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing

H. Goossens, P. van Damme, I. De Coster, 2016, International journal of molecular sciences.

Optimization of HPV DNA detection in urine by improving collection, storage, and extraction

M. Ieven, P. Damme, A. Vorsters, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Letter to the editor: female sex workers and HPV vaccine

P. van Damme, A. Hogewoning, M. F. Schim van der Loeff, 2019, Human vaccines & immunotherapeutics.

Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology

P. van Damme, S. Wiersma, K. Herck, 2008, Journal of viral hepatitis.

Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study

J. Doyen, S. Weyers, M. Arbyn, 2021, Archives of Public Health.

Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan

S. Franceschi, P. Snijders, M. Tommasino, 2017, Virology Journal.

A summer school on vaccinology: Responding to identified gaps in pre-service immunisation training of future health care workers.

P. Bonanni, P. Damme, H. Heijbel, 2010, Vaccine.

Reduced Prevalence of HBsAg Variants following a Successful Immunization Program in China

P. van Damme, M. Kane, H. Norder, 2014, Journal of Virology.

Detection of human papillomavirus DNA in urine. A review of the literature

M. Ieven, P. Damme, J. Bilcke, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

First-void urine as a non-invasive liquid biopsy source to detect vaccine-induced human papillomavirus antibodies originating from cervicovaginal secretions.

N. Hens, P. van Damme, X. Van Ostade, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

First-void urine: A potential biomarker source for triage of high-risk human papillomavirus infected women.

P. van Damme, X. Van Ostade, M. Ieven, 2017, European journal of obstetrics, gynecology, and reproductive biology.

Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan

S. Franceschi, M. Tommasino, P. Snijders, 2017, Virology Journal.

HPV DNA detection in urine samples of women: ‘an efficacious and accurate alternative to cervical samples?’

P. van Damme, Jade Pattyn, S. Van Keer, 2019, Expert review of anti-infective therapy.

Introducing universal hepatitis B vaccination in Europe: differences still remain between countries

K. Herck, E. Leuridan, P. Damme, 2004 .

HPV prevention and control – The way forward

M. Poljak, S. Garland, M. Stanley, 2022, Preventive Medicine.

Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan

S. Franceschi, M. Tommasino, G. Clifford, 2020, Emerging infectious diseases.

Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox

H. Goossens, N. Hens, P. van Damme, 2017, Scientific Reports.

Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.

F. X. Bosch, P. van Damme, M. Kane, 2012, Vaccine.

Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?

P. van Damme, E. Karafillakis, R. Limaye, 2023, Frontiers in Public Health.

Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory

M. Poljak, L. Alemany, K. Cuschieri, 2023, Journal of clinical microbiology.

Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives

R. Limaye, Dominique Guillaume, A. Vorsters, 2022, Human vaccines & immunotherapeutics.

State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop

S. Madhi, H. Rees, A. Moscicki, 2023, Preventive medicine reports.

Comprehensive control of human papillomavirus infections and related diseases.

M. Plummer, M. Poljak, J. Ferlay, 2013, Vaccine.

Validation of BD Onclarity HPV assay on vaginal self-samples versus cervical samples using the VALHUDES protocol.

S. Weyers, M. Arbyn, W. Tjalma, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Hepatitis A and E: update on prevention and epidemiology.

P. van Damme, D. Fitzsimons, A. Vorsters, 2010, Vaccine.

HPV vaccination, are we overlooking additional opportunities to control HPV infection and transmission?

P. van Damme, X. Bosch, A. Vorsters, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report

D. Watson-Jones, N. Mugo, C. Eklund, 2023, Preventive medicine reports.

Clinical accuracy of Alinity m HR HPV assay on self- versus clinician-taken samples using the VALHUDES protocol.

S. Van Keer, A. Vorsters, Gilbert Donders, 2023, The Journal of molecular diagnostics : JMD.

Prevention and control of HPV and HPV-related cancers in France: the evolving landscape and the way forward – a meeting report

N. Muñoz, E. Franco, C. Olivier, 2023, BMC Proceedings.

HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity.

W. D. De Vos, F. Molenberghs, Laura Téblick, 2024, Human vaccines & immunotherapeutics.

Concentration strategies for spiked and naturally present biomarkers in non-invasively collected first-void urine

V. Matheeussen, Laura Téblick, A. Vorsters, 2024, European journal of medical research.

Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium

H. Goossens, N. Hens, P. van Damme, 2016, BMC Public Health.